Moors & Cabot’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,438
Closed -$321K 864
2024
Q1
$321K Buy
2,438
+663
+37% +$81.6K 0.02% 648
2023
Q4
$256K Buy
1,775
+508
+40% +$69.8K 0.02% 672
2023
Q3
$215K Buy
1,267
+194
+18% +$38.6K 0.01% 722
2023
Q2
$239K Buy
1,073
+67
+7% +$13.7K 0.02% 694
2023
Q1
$222K Sell
1,006
-17
-2% -$4.19K 0.02% 717
2022
Q4
$222K Sell
1,023
-85
-8% -$22.7K 0.02% 701
2022
Q3
$293K Sell
1,108
-75
-6% -$19.1K 0.02% 568
2022
Q2
$247K Sell
1,183
-60
-5% -$13.4K 0.02% 624
2022
Q1
$275K Buy
+1,243
New +$263K 0.02% 656

Other funds holding ALB

Moors & Cabot's ALB Position: Q2 2024 in Review

Moors & Cabot sold out of Albemarle (ALB) in Q2 2024, closing a stake of 2,438 shares — an estimated $321K sold.

Moors & Cabot first reported a position in ALB in Q1 2022 and held it in 9 quarters. The position peaked at $321K in Q1 2024. 843 funds tracked by Wall St. Rank hold ALB as of Q2 2024.

  • Moors & Cabot reported no remaining Albemarle position as of Q2 2024 after selling out during the quarter.
  • Moors & Cabot sold 2,438 Albemarle shares in Q2 2024, an estimated $321K.
  • Moors & Cabot first reported a position in Albemarle in Q1 2022 and held it in 9 quarters.
  • Moors & Cabot's Albemarle position peaked at $321K in Q1 2024.
  • 843 funds tracked by Wall St. Rank held Albemarle as of Q2 2024.

Based on Moors & Cabot's 13F filing for Q2 2024, filed 9 Aug 2024.